Pathology Asia Holdings logo

Pathology Asia Holdings

Asia, Central Region, Singapore, Singapore

Description

Pathology Asia Holdings is a medical diagnostics group.

Investor Profile

Pathology Asia Holdings has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Which angels does Pathology Asia Holdings often collaborate with?

MW
Europe, Stockholms Lan, Sweden, Stockholm
Shared Deals: 1

What are some of recent deals done by Pathology Asia Holdings?

Bluestar Genomics

San Diego, California, United States

Bluestar Genomics is a company that delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing.

BiopharmaBiotechnologyHealth Care
Series CMay 12, 2021
Amount Raised: $70,000,000